Abstract:Background: Keloids represent a dysregutated response to cutaneous wounding that result in an excessive deposition of extracellular matrix (ECM), especially types I and III collagen. In keloid scars, the ratio of 'type I to type III collagen' varies compared to normal skin. Transforming growth factor P (TGF-beta) plays a central role in the pathogenesis of fibrosis by inducing and sustaining activation of keloid fibroblasts. However, the underlying mechanisms are poorly understood. RNA interference (RNAi) is an evollutionally conserved mechanism for repressing targeted gene expression. In mammalian cells, RNAi is mediated by small interfering RNA (siRNA). In this paper, we examined the function of Sma and Drosophila mothers against decapentaptegic homotog 3 (Smad3), recently characterized as intracellular effector of TGF-beta signalling, in ketoid fibroblasts using siRNA.Methods: Dermal fibroblasts obtained from one female patient aged 21 years were maintained in Dulbecco's modified Eagle's medium. Cells (<6 passages) were treated with or without Smad3 siRNA and the expression levels of related genes were examined by Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western Blot. Statistical analysis was performed using one-way ANOVA (Dunnett correction) and the Excel 7.0 software, with significance set at p < 0.05.Results: The knockdown of Smad3 expression in mRNA and protein levels was confirmed using RT-PCR and Western Blot. Compared to blank, the mRNA levels of types I and III procoltagen were also significantly and uniquely decreased following the reduction of Smad3 by siRNA (p < 0.05).The results indicate that Smad3 plays an important role in the TGF-beta induced fibrosis in keloid. Downregutation of Smad3 expression in keloid fibroblasts can significantly decrease procollagen gene expression. SiRNA targeting Smad3 was an efficient reagent to reduce ECM deposition and attenuate process of fibrosis. It could be a new promising therapeutic approach to improve skin wound heating and inhibit progression of fibrotic conditions by interrupting the TGF-beta signal pathway. (C) 2006 Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.

Knockdown of FOXM1 Inhibits Activation of Keloid Fibroblasts and Extracellular Matrix Production Via Inhibition of TGF-β1/Smad Pathway.

Expression of Smad3 mRNA and Smad7 mRNA of TGF-β1 in keloid-derived fibroblasts

Hypoxia-inducible Factor-1Α Activates Transforming Growth Factor-Β1/smad Signaling and Increases Collagen Deposition in Dermal Fibroblasts

HIF-1α Promotes the Keloid Development Through the Activation of TGF-β/Smad and TLR4/MyD88/NF-κB Pathways.

The mechanism of TGF-β mediating BRD4/STAT3 signaling pathway to promote fibroblast proliferation and thus promote keloid progression

MiR-152-3p Regulates Cell Proliferation, Invasion and Extracellular Matrix Expression Through by Targeting FOXF1 in Keloid Fibroblasts

TWEAK/Fn14 Signaling May Function As a Reactive Compensatory Mechanism Against Extracellular Matrix Accumulation in Keloid Fibroblasts.

Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway

Increased Cthrc1 Activates Normal Fibroblasts and Suppresses Keloid Fibroblasts by Inhibiting TGF-β/Smad Signal Pathway and Modulating YAP Subcellular Location

Twist-related protein 1 promotes transforming growth factor β receptor 1 in keloid fibroblasts via regulating the stability of myocyte enhancer factor 2A

BMP1 Promotes Keloid by Inducing Fibroblast Inflammation and Fibrogenesis

TGF-β1 Induces Polypyrimidine Tract-Binding Protein to Alter Fibroblasts Proliferation and Fibronectin Deposition in Keloid

Peroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression.

Tgf-Beta 1 Induces Polypyrimidine Tract-Binding Protein To Alter Fibroblasts Proliferation And Fibronectin Deposition In Keloid

Overexpression of Mir-133A-3p Inhibits Fibrosis and Proliferation of Keloid Fibroblasts by Regulating IRF5 to Inhibit the TGF-β/Smad2 Pathway

Increased Sensitivity to TNF‑α Promotes Keloid Fibroblast Hyperproliferation by Activating the NF‑κB, JNK and P38 MAPK Pathways

Sumoylation Enhances the Activity of the TGF-β/SMAD and HIF-1 Signaling Pathways in Keloids

Inhibition of Smad3 Expression Decreases Collagen Synthesis in Keloid Disease Fibroblasts

MicroRNA-152-5p inhibits proliferation and migration and promotes apoptosis by regulating expression of Smad3 in human keloid fibroblasts

Single-cell RNA sequencing analysis reveals the role of TXNDC5 in keloid formation

Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway